Antares Vision S p A: PR – Procedures and Exercise Ratio – April 20, 2022.pdf


Travagliato (BS), April 20, 2022 – Antares Vision SpA (“Antares Vision“or the”Company“) announces that, in accordance with Article 3 of the Rules of “Warrants Antares Vision SpA” (respectively, the “Warrant Rules1 and the “Mandates“), the Monthly Average Price for the month of March 2022 is 8.5857 euros (source FactSet, Monthly Average Price calculated as the arithmetic mean of the official prices of Antares Vision SpA ordinary shares on trading days in March) .

Thus, the Average Monthly Price of March 2022, equal to 8.5857 euros, being lower than the Exercise Price, equal to 9.50 euros, the Warrants cannot be exercised during the month of April 2022.

We remind you that, in accordance with the financial calendar of the Company previously made public on January 18, 2022 and taking into account the General Meeting of shareholders of the Company fixed, on a single date, on April 22, 2022, the Exercise Period, in accordance to Article 3.12 of the Warrants Regulations is automatically suspended until April 22, 2022 inclusive.

Antares Vision also announces that in March, no exercise requests were received. Consequently, the share capital of Antares Vision (169,452.91 euros, divided into 69,119,526 ordinary shares, 250,000 special shares and 1,189,590 performance shares, with no indication of nominal value for any category) remained unchanged as well as the warrants in circulation (equal to 2,490,400).

For any additional information, please refer to the BSA Regulations available on the Antares Vision“Investors – Investor Relations – Warrant” section.


Antares Vision Group is an exceptional technological partner in digitization and innovation for companies and institutions, guaranteeing the safety of products and people, the competitiveness of companies and the protection of the environment.

Antares Vision Group is a technological catalyst for supply chain transparency and sustainable transition, to protect the competitiveness of companies and the specificity of each country.

It provides a unique and comprehensive ecosystem of technologies to ensure product quality (systems and inspection equipment) and end-to-end product traceability (from raw materials to production, from distribution to consumer), with management integrated data, production and supply chain. , also achieved through the application of artificial intelligence and the use of blockchains.

Antares Vision Group is active in the life sciences sector (pharmaceuticals, biomedical devices and hospitals), in the beverage, food and cosmetics industries, and has potential in other sectors. World leader in Track&Trace systems for pharmaceutical products, it provides large global manufacturers (more than 50% of the top 20 multinationals) and many government authorities with solutions to monitor their supply chains and validate the authenticity of products.

Listed since April 2019 on the Italian Stock Exchange on the AIM (Alternative Investment Market) segment, and since May 14, 2021 on the STAR segment of the MTA (Electronic equity market), Antares Vision Group has achieved a turnover of 162 million euros. euro in 2020, operates in 60 countries, employs approximately 1,000 people and has a consolidated network of more than 40 international partners.

1 The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Settlement.

More information please visitwww.antaresvision.comand

For more information




JEL.: +39 030 72 83 500


Sallie R. Loera